|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2001-12-13
|
|
pubmed:abstractText |
Due to the high mortality rates from gallbladder carcinoma in Chile, we conducted a phase II trial to test the efficacy and safety of gemcitabine in patients with locally advanced or metastatic gallbladder carcinoma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1403-6
|
|
pubmed:dateRevised |
2004-12-9
|
|
pubmed:meshHeading |
pubmed-meshheading:11762811-Adult,
pubmed-meshheading:11762811-Aged,
pubmed-meshheading:11762811-Antimetabolites, Antineoplastic,
pubmed-meshheading:11762811-Carcinoma,
pubmed-meshheading:11762811-Deoxycytidine,
pubmed-meshheading:11762811-Disease-Free Survival,
pubmed-meshheading:11762811-Female,
pubmed-meshheading:11762811-Fever,
pubmed-meshheading:11762811-Gallbladder Neoplasms,
pubmed-meshheading:11762811-Hemorrhage,
pubmed-meshheading:11762811-Humans,
pubmed-meshheading:11762811-Infusions, Intravenous,
pubmed-meshheading:11762811-Male,
pubmed-meshheading:11762811-Middle Aged,
pubmed-meshheading:11762811-Neutropenia,
pubmed-meshheading:11762811-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
A phase II study of gemcitabine in gallbladder carcinoma.
|
|
pubmed:affiliation |
Sección Oncología, Hospital Clínico José Joaquín Aguirre Universidad de Chile, Santiago. jgallard@ns.hospital.uchile.cl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
